PCBL Chemical Stock Dips 2% as FY26 Net Profit Plummets 54% Amid Margin Squeeze

Synopsis: Weighed down by compressed carbon black margins, elevated finance costs from the Aquapharm acquisition, and a sharp Q3 deceleration, PCBL Chemical posted consolidated PAT of Rs.198 crore for FY26 even as the company commissioned fresh capacity in Tamil Nadu that positions it for a volume recovery when spreads stabilise.

Shares of India’s largest carbon black producer came under scrutiny on April 30, 2026, as the company announced audited results for the quarter and financial year ended March 31, 2026. Full-year consolidated revenue came in at Rs.8,189 crore, a 2.6 percent decline from Rs.8,404 crore in FY25

With a market capitalisation of Rs. 11,502.88 crore, the shares of PCBL Chemical Ltd were trading at Rs. 292.35 per share, down 2.14 percent from its previous closing price of Rs. 298.73 apiece. It is trading at a P/E of 45.56.

Consolidated revenue from operations for FY26 was Rs.8,189.30 crore against Rs.8,404.25 crore in FY25. Consolidated PAT attributable to equity shareholders was Rs.197.87 crore, down sharply from Rs.434.60 crore a 54.5 percent decline.

The standalone picture is similar: revenue fell to Rs.5,576.05 crore from Rs. 5,904.63 crore, and PAT dropped from Rs.451.06 crore to Rs.235.82 crore. Q4 FY26 consolidated revenue at Rs.2,066.06 crore was marginally lower than Q4 FY25’s Rs.2,087.49 crore, but the sequential improvement from Q3’s weak Rs.1,845.62 crore is notable.

The main drag on profitability is double-pronged. First, carbon black spreads: the gap between selling prices and raw material (feedstock) costs, compressed through much of FY26, lowering operating margins from the 15 to 17 percent range seen in FY24 to between 10 and 13 percent for most of FY26.

Second, the Aquapharm Chemical acquisition (formerly Advaya Chemical Industries) carried over full-year finance costs of Rs. 422.98 crore on the consolidated books  more than 2x what the group paid in FY24 without yet delivering a proportionate earnings uplift. The Chemical segment (primarily Aquapharm’s phosphonate business) contributed Rs.17.43 crore in segment profit for FY26 against Rs.65.59 crore in FY25, a steep fall that underscores the challenges in integrating a large specialty chemicals acquisition.

The more forward-looking development is on the production side. PCBL (TN) Limited, a wholly owned subsidiary, commenced commercial production of Line 4 at its Tamil Nadu plant effective January 28, 2026, adding 60,000 MT of annual carbon black capacity. A further brownfield expansion of 30,000 MT at the same facility commenced production from March 27, 2026.

Combined, these additions bring the group’s total installed capacity to approximately 790 KTPA. The Andhra Pradesh government also issued a final allotment order for 116.62 acres of land at SEZ Naidupeta in favour of PCBL (TN) Limited, enabling a new carbon black plant though timeline and capital outlay for this project were not specified in the filing.

The immediate near-term question is whether the group’s existing leverage can be serviced comfortably through a period of margin softness. The standalone DSCR stood at 1.11 for FY26 (without prepayment), down from 1.25 in FY25, which is thin but not distressed.

Business Overview

Incorporated in 1960, PCBL Chemical Limited (formerly PCBL Limited) is a part of the RP-Sanjiv Goenka Group, listed on both the BSE (scrip code: 506590) and NSE (symbol: PCBL). The company is India’s largest carbon black producer, with a total capacity of 790 KTPA, and ranks among the top 3 global producers of phosphonates through its Aquapharm subsidiary. For FY25, the company reported consolidated revenue of Rs.8,404 crore and net profit of Rs.435 crore.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post PCBL Chemical Stock Dips 2% as FY26 Net Profit Plummets 54% Amid Margin Squeeze appeared first on Trade Brains.